Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
DINOPROST (AS DINOPROST TROMETATOL PH.EUR.)
Zoetis Ireland Limited
QG02AD01
DINOPROST (AS DINOPROST TROMETATOL PH.EUR.)
5 Mg/Ml
Solution for Injection
POM: Prescription Only Medicine as defined in relevant national legislation
Bovine, Equine - Food, Porcine
dinoprost
Hormone
Authorised
2013-10-18
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Lutalyse. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 3 PHARMACEUTICAL FORM Solution for Injection. A clear aqueous solution. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle, horses and pigs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Lutalyse is indicated for its luteolytic and/or oxytocic effects in cattle, horses and pigs. The indications for use are: CATTLE 1. To more effectively control the time of oestrus in cycling cows. 2. To treat cows which have a functional corpus luteum, but do not express behavioural oestrus (sub-oestrus or silent heat). 3. To induce abortion. 4. To induce parturition. 5. For treatment of chronic metritis and pyometra. 6. For controlled breeding in normally-cycling dairy cows: oestrus synchronisation ovulation synchronisation in combination with GnRH or GnRH analogues as part of fixed time artificial insemination protocols. MARES 1. To more effectively control the time of oestrus in cycling mares. 2. To treat mares which have a functional corpus luteum but do not express behavioural oestrus. 3. To induce abortion. PIGS 1. Induction of parturition. 2. To reduce the weaning to oestrus interval (WOI) and the weaning to fertile service interval (WFSI) in sows in herds with reproductive problems. Each ml contains: Active Substance Dinoprost (as Dinoprost Trometamol) 5 mg Excipients Benzyl Alcohol 16.5 mg For a full list of excipients, see section 6.1 H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P Read the complete document